Skip to main content
Clinical Trials/CTRI/2022/09/045736
CTRI/2022/09/045736
Not yet recruiting
Phase 4

To compare the efficacy of two combination therapies against carbapenem resistant enterobacteriaceaeMeropenem plus colistin versus high dose tigecycline plus colistin in critically ill patients.

Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: R799- Abnormal finding of blood chemistry, unspecified
Sponsor
Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient having sepsis and SOFA score of 2 or more than 2 at the time of admission in icu/ccw.
  • 2\.There should be an isolates of carbapenem resistant enterobacteriaceae (CRE) positive either from Blood, tracheal aspirates, urine or abdominal pus culture.
  • 3\.Patient on any empirical antibiotics except current combination therapy .

Exclusion Criteria

  • 1\.Patient who is not having sepsis and having SOFA score of less than 2\. Non Carbapenem resistant enterobacteriaceae (CRE) patients.
  • 3\.Patient who expire within 48 hours of starting the combination
  • 4\.Patient having sensitivity to the drug use .
  • 5\.Covid \-19 positive patients

Outcomes

Primary Outcomes

Not specified

Similar Trials